Minor depression and brain perfusion images in Parkinson's disease

Movement Disorders

Volumn 21, Issue 8, 2006, Pages 1169-1174

  Matsui, Hideaki ^a   Nishinaka, Kazuto ^a   Oda, Masaya ^a   Komatsu, Kenichi ^a   Kubori, Tamotsu ^a   Udaka, Fukashi ^a  

^a SUMITOMO HOSPITAL   (Japan)

Author keywords

Brodmann area 10; Frontal dysfunction; Minor depression; Parkinson's disease; SPECT

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; IOFETAMINE I 123; LEVODOPA; PERGOLIDE; PRAMIPEXOLE;

ADULT; AGED; ARTICLE; BRAIN PERFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; FEMALE; FRONTAL CORTEX; HAMILTON SCALE; HUMAN; IMAGE ANALYSIS; MAJOR DEPRESSION; MALE; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RATING SCALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; WISCONSIN CARD SORTING TEST;

AGED; BRAIN; BRAIN MAPPING; FUNCTIONAL LATERALITY; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PARKINSON DISEASE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 33748342570     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.20923     Document Type: Article

References (39)

1. Shulman LM, Taback RL, Bean J, Weiner WJ. Comorbidity of the nonmotor symptoms of Parkinson's disease. Mov Disord 2001;16: 507-510.
2. Menza MA, Robertson-Hoffman DE, Bonapace AS. Parkinson's disease and anxiety: comorbidity with depression. Biol Psychiatry 1993;34:465-470.
3. Yamamoto M. Depression in Parkinson's disease: its prevalence, diagnosis, and neurochemical background. J Neurol 2001; 248(Suppl. 3):III5-III11.
4. Poewe W, Seppi K. Treatment options for depression and psychosis in Parkinson's disease. J Neurol 2001;248(Suppl. 3):III12-III21.
5. Baumann B, Danos P, Krell D, et al. Reduced volume of limbic system-affiliated basal ganglia in mood disorders: preliminary data from a postmortem study. J Neuropsychiatry Clin Neurosci 1999; 11:71-78.
6. Husain MM, McDonald WM, Doraiswamy PM, et al. A magnetic resonance imaging study of putamen nuclei in major depression. Psychiatry Res 1991;40:95-99.
7. Krishnan KR, McDonald WM, Escalona PR, et al. Magnetic resonance imaging of the caudate nuclei in depression: preliminary observations. Arch Gen Psychiatry 1992;49:553-557.
8. Drevets WC, Videen TO, Price JL, Preskorn SH, Carmichael ST, Raichle ME. A functional anatomical study of unipolar depression. J Neurosci 1992;12:3628-3641.
9. Brunswick DJ, Amsterdam JD, Mozley PD, Newberg A. Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging. Am J Psychiatry 2003;160:1836-1841.
10. Mayberg HS, Starkstein SE, Sadzot B, et al. Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease. Ann Neurol 1990;28:57-64.
11. Mentis MJ, McIntosh AR, Perrine K, et al. Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease. Am J Psychiatry 2002;159:746-754.
12. Ring HA, Bench CJ, Trimble MR, Brooks DJ, Frackowiak RS, Dolan RJ. Depression in Parkinson's disease: a positron emission study. Br J Psychiatry 1994;165:333-339.
13. Hughes AJ, Daniel SE, Kilford L, Lees AL Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-194.
14. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
15. Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94-98.
16. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995;36:1238-1248.
17. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997;42:85-94.
18. Lancaster JL, Woldorff MG, Parsons LM, et al. Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapping 2000;10:120-131.
19. Lancaster JL, Rainey LH, Summerlin JL, et al. Automated labeling of the human brain: a preliminary report of the development and evaluation of a forward-transform method. Hum Brain mapping 1997;5:238-242.
20. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. New York: Thime Medical Publishers; 1988.
21. Robinson RG, Kubos KL, Starr LB, Rao K, Price TR. Mood disorders in stroke patients: importance of location of lesion. Brain 1984;107:81-93.
22. Starkstein SE, Robinson RG, Price TR. Comparison of cortical and subcortical lesions in the production of poststroke mood disorders. Brain 1987;110:1045-1059.
23. Grafman J, Vance SC, Weingartner H, Salazar AM, Amin D. The effects of lateralized frontal lesions on mood regulation. Brain 1986;109:1127-1148.
24. Eslinger PJ, Damasio AR. Severe bilateral disturbance of higher cognition after bilateral frontal ablation: patient EVR. Neurology 1985;55:1731-1741.
25. Jolles PR, Chapman PR, Alavi A. PET, CT, and MRI in the evaluation of neuropsychiatric disorders: current applications. J Nucl Med 1989;30:1589-1606.
26. Mayberg HS, Jeffery PJ, Wagner HN, Simpson SG. Regional cerebral blood flow in patients with refractory umpolar depression measured with Tc-99-HMPAO SPECT. J Nucl Med 1991;32: S951.
27. Maes M, Dierckx R, Meltzer HY, et al. Regional cerebral blood flow in unipolar depression measured with Tc-99m-HMPAO single photon emission computed tomography: negative findings. Psychiatry Res 1993;50:77-88.
28. Starkstein SE, Mayberg HS, Leiguarda R, Preziosi TJ, Robinson RG. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1992;55:377-382.
29. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986;9:357-381.
30. Dennis J. A review of the cognitive and behavioral sequelae of Parkinson's disease: relationship to frontostriatal circuitry. Cogn Behav Neurol 2003;16:193-210.
31. Meyer JH, Kruger S, Wilson AA, et al. Lower doparnine transporter binding potential in striatum during depression. Neuroreport 2001;12:4121-4125.
32. Halliday GM, Li YW, Blumbergs PC, et al. Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease. Ann Neurol 1990;27:373-385.
33. Brown R, Jahanshahi M. Depression in Parkinson's disease: a psychosocial viewpoint. In: Weiner WJ, Lang AE, editors. Behavioral neurology of movement disorders, vol. 65. New York: Raven Press; 1995. p 61-84.
34. Tom T, Cummings JL. Depression in Parkinson's disease: pharmacological characteristics and treatment. Drugs Aging 1998;12: 55-74.
35. Remy P, Doder M, Lees A, Turjanski N, Brooks D. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005;128:1314-1322.
36. Simon H, Le Moal M, Calas A. Efferents and afferents of the ventral tegmental-AlO region studied after local injection of [3H]leucine and horseradish peroxidase. Brain Res 1979;178:17-40.
37. Azmitia EC, Gannon PJ. Primate serotonergic system: a review of human and animal studies and a report on Macaca fascicularis. Adv Neurol 1986;43:407-468.
38. Starkstein SE, Robinson RG, Berthier ML, Parikh RM, Price TR. Differential mood changes following basal ganglia vs thalamic lesions. Arch Neurol 1988;45:725-730.
39. Steffens DC, Tupler LA, Ranga K, Krishnan R. Magnetic resonance imaging signal hypointensity and iron content of putamen nuclei in elderly depressed patients. Psychiatry Res 1998;83:95-103.